Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/JOHNSON-JOHNSON-4832/news/RYBREVANT-amivantamab-vmjw-in-Combination-With-Chemotherapy-Is-the-First-FDA-Approved-Therapy-fo-46077039/?utm_source=whatsapp&utm_medium=social&utm_campaign=share